Lista de obras -

A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy

artículo científico publicado en 2012

Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.

artículo científico publicado en 2011

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

artículo científico publicado en 2010

Anaplastic gliomas in adults: an update

artículo científico publicado en 2017

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

artículo científico publicado en 2008

Anti-NMDA-R encephalitis: Should we consider extreme delta brush as electrical status epilepticus?

artículo científico publicado en 2016

Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis

artículo científico publicado en 2013

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis

artículos científicos

Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer

artículo científico publicado en 2013

CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas

artículo científico publicado en 2015

Characteristics of gliomas in patients with somatic IDH mosaicism

artículo científico publicado en 2016

Chemotherapy for diffuse low-grade gliomas in adults ⬇️

artículo científico publicado el 8 de septiembre de 2011

Chemotherapy in low-grade gliomas

artículo científico publicado en 2012

Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases

scientific article published in 2022

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression

scientific article published on 18 December 2013

Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties

artículo científico publicado en 2011

Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors

artículo científico publicado en 2020

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies

artículo científico publicado en 2007

Diagnostic and prognostic markers in gliomas

artículo científico publicado en 2009

Genomic changes in progression of low-grade gliomas

artículo científico publicado en 2008

Increasing the Time Interval between PCV Chemotherapy Cycles as a Strategy to Improve Duration of Response in Low-Grade Gliomas: Results from a Model-Based Clinical Trial Simulation

artículo científico publicado en 2015

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas

artículo científico publicado en 2016

Limbic encephalitis. A misdiagnosed syndrome

artículo científico publicado en 2008

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

artículo científico publicado en 2010

Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations

artículo científico publicado en 2014

Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas

artículo científico publicado en 2016

Molecular genetic markers as predictors of response to chemotherapy in gliomas

artículo científico publicado en 2007

Multinodular and Vacuolating Posterior Fossa Lesions of Unknown Significance

artículo científico publicado en 2019

Neuroleptic intolerance in patients with anti-NMDAR encephalitis

artículo científico publicado en 2016

New targeted therapies in pituitary carcinoma resistant to temozolomide

artículo científico publicado en 2012

Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France

artículo científico publicado en 2014

Peri-ictal pseudoprogression in patients with brain tumor

artículo científico publicado en 2011

Postradiation lumbosacral radiculopathy with spinal root cavernomas mimicking carcinomatous meningitis

artículo científico publicado en 2008

Predictive and prognostic factors for gliomas

artículo científico publicado en 2011

Predictive biomarkers in adult gliomas: the present and the future

artículo científico publicado en 2013

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

artículo científico publicado en 2016

Prognostic markers in gliomas

artículo científico publicado en 2010

Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma

artículo científico publicado en 2016

Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas

artículo científico publicado en 2010

Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates

artículo científico

SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas

artículo científico publicado en 2012

Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial

artículo científico publicado en 2011

Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors

artículo científico publicado en 2008

Treating glioblastoma patients with poor performance status: where do we go from here?

artículo científico publicado en 2014

Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial

scientific article published on 17 August 2016

Lista de obras de

A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy

Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

Anaplastic gliomas in adults: an update

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

Anti-NMDA-R encephalitis: Should we consider extreme delta brush as electrical status epilepticus?

Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis

Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer

CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas

Characteristics of gliomas in patients with somatic IDH mosaicism

Chemotherapy for diffuse low-grade gliomas in adults ⬇️

Chemotherapy in low-grade gliomas

Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression

Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties

Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies

Diagnostic and prognostic markers in gliomas

Genomic changes in progression of low-grade gliomas

Increasing the Time Interval between PCV Chemotherapy Cycles as a Strategy to Improve Duration of Response in Low-Grade Gliomas: Results from a Model-Based Clinical Trial Simulation

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas

Limbic encephalitis. A misdiagnosed syndrome

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations

Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas

Molecular genetic markers as predictors of response to chemotherapy in gliomas

Multinodular and Vacuolating Posterior Fossa Lesions of Unknown Significance

Neuroleptic intolerance in patients with anti-NMDAR encephalitis

New targeted therapies in pituitary carcinoma resistant to temozolomide

Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France

Peri-ictal pseudoprogression in patients with brain tumor

Postradiation lumbosacral radiculopathy with spinal root cavernomas mimicking carcinomatous meningitis

Predictive and prognostic factors for gliomas

Predictive biomarkers in adult gliomas: the present and the future

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

Prognostic markers in gliomas

Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma

Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas

Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates

SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas

Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial

Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors

Treating glioblastoma patients with poor performance status: where do we go from here?

Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial